Brucellosis in Cattle: Diagnosis and Control Strategies

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Brucella abortus is the primary agent of bovine brucellosis, a zoonotic disease characterized by late-term abortions, retained placentas, and orchitis in bulls; asymptomatic carriers are common, necessitating diagnostic testing over clinical observation.
• Diagnostic challenges stem from non-specific clinical signs and the absence of a single test with high sensitivity and specificity across all infection stages and vaccination statuses, requiring interpretation within a probabilistic framework considering herd prevalence and vaccination history.
• Serological screening tests like the Rose Bengal test (RBT) and ELISA are highly sensitive but prone to false positives due to cross-reactivity with organisms such as Yersinia enterocolitica O:9; confirmatory tests like the Complement Fixation Test (CFT) are more specific but technically demanding.
• Vaccination with B. abortus strain S19 induces antibodies detectable by standard serology, complicating diagnosis, while strain RB51, a rough mutant, does not induce such antibodies, simplifying surveillance but creating a diagnostic gap for vaccine-induced immunity.
• Control strategies involve a two-tier diagnostic approach (screening followed by confirmation), test-and-slaughter, vaccination, and stringent biosecurity measures, with eradication efforts guided by international standards (e.g., WOAH) and national regulatory frameworks.
• The gamma interferon (IFN-γ) assay measures cell-mediated immunity and can detect infection earlier than serological methods, but its specificity is antigen-dependent and can be compromised by cross-reactivity with Y. enterocolitica O:9, necessitating careful antigen selection and validation.

Brucellosis in cattle, caused principally by Brucella abortus, remains a globally significant zoonosis with major consequences for herd productivity, international trade, and public health. This reference article serves practicing veterinarians engaged in herd health programs, regulatory diagnostics, and reproductive investigations. It addresses the clinical presentations that prompt testing, the performance characteriztics of available diagnostic modalities, and the control frameworks that govern eradication efforts across different production systems.

The diagnostic challenge in bovine brucellosis is twofold. First, clinical signs are often non-specific or absent, with abortion in the last trimester being the most consistent indicator. Second, no single test offers both high sensitivity and high specificity across all stages of infection, vaccination statuses, and exposure histories. The practitioner must therefore interpret laboratory results within a probabilistic framework that accounts for herd prevalence, vaccination history, and the presence of cross-reacting organizms. This article provides the reasoning structure for that interpretation, from initial screening through confirmatory testing to regulatory action.

At a Glance

Pathogenesis and Host-Pathogen Interactions

B. abortus establishes infection through mucosal surfaces, most commonly the oropharynx following ingestion of contaminated feed, water, or aborted material. The organizm survives within phagocytes, exploiting the intracellular environment to evade humoral immunity. Erythritol, a sugar alcohol concentrated in the bovine placenta and fetal tissues, promotes bacterial replication in the pregnant uterus, explaining the characteriztic predilection for the gravid reproductive tract.

The immune response evolves in a predictable sequence that underpins diagnostic test selection. IgM antibodies appear first, followed by IgG1 and IgG2. The serological cross-reactivity between B. abortus and Yersinia enterocolitica O:9 complicates interpretation, as both organizms share immunodominant lipopolysaccharide (LPS) epitopes. This cross-reactivity is a principal cause of false-positive serological reactions in herds with no history of brucellosis exposure.

Cell-mediated immunity develops concurrently with the humoral response. The in vitro antigen-specific gamma interferon production assay exploits this arm of the immune response, measuring IFN-gamma release from sensitized lymphocytes after stimulation with Brucella cytoplasmic proteins. This test detects infection earlier than serological methods in experimentally infected cattle, but its specificity is compromised by cross-reactivity with Y. enterocolitica O:9, as demonstrated in experimental infection studies.

Clinical Presentation and Diagnostic Triggers

Reproductive Signs

Abortion is the hallmark of bovine brucellosis, typically occurring between the fifth and seventh month of gestation. The dam often retains the placenta, and subsequent fertility may be impaired. Not all infected cows abort, a proportion seroconvert and carry calves to term while remaining persistently infected. These animals shed organizms in uterine discharges at subsequent parturitions and in milk, perpetuating herd transmission.

Non-Reproductive Signs

Orchitis and epididymitis occur in infected bulls, with seminal shedding possible. Arthritis, hygromas, and mastitis are less common but documented manifestations. Many infected animals show no clinical signs at all, which is why diagnostic testing instead of clinical observation drives detection.

When to Test

Testing is indicated when abortion storms occur, when replacement animals are introduced, for pre-purchase screening, and as part of regional eradication campaigns. The Society for Theriogenology resources provide guidance on integrating brucellosis screening into routine reproductive health assessments, particularly for breeding soundness examinations of bulls.

Serological Testing: Principles and Interpretation

Screening Assays

The Rose Bengal test (RBT) is the most widely used screening assay. It is inexpensive, rapid, and highly sensitive, but false positives occur, particularly in vaccinated herds and in herds exposed to cross-reacting organizms. The card test operates on the same principle and is used in some field settings.

ELISA-based methods, both indirect and competitive, offer improved throughput and objective readouts. The enzymatic rapid immunofiltration assay (ERIFA) represents a point-of-care adaptation, producing results within five minutes with diagnostic performance comparable to laboratory ELISA in comparative evaluations.

Confirmatory Assays

The complement fixation test (CFT) has historically served as the confirmatory assay in most eradication programs. It is highly specific but technically demanding, requiring careful standardization of reagents and complement activity. The CFT also detects antibodies induced by vaccination with B. abortus RB51 when the rough strain is used as antigen, a property that can distinguish vaccinated from infected animals in some contexts.

The False-Positive Problem

False-positive serological reactions (FPSRs) arise from infection with Y. enterocolitica O:9, Salmonella species, and certain other Gram-negative organizms. The IFN-gamma assay was initially proposed as a discriminatory test, but subsequent experimental work showed that oral exposure to Y. enterocolitica O:9 produces IFN-gamma responses above the cut-off threshold in a high proportion of animals, undermining its specificity for B. abortus.

Vaccination and Its Impact on Diagnostics

Two vaccines are in common use. Strain 19 (S19) is a smooth, live attenuated vaccine that induces strong protective immunity but also produces antibodies detectable by standard serological tests, complicating the distinction between vaccinated and infected animals. Strain RB51 is a rough mutant lacking the O-polysaccharide side chain of LPS, so it does not induce antibodies reactive in standard serological assays. This property simplifies post-vaccination surveillance but creates a diagnostic gap: RB51-vaccinated animals that become infected with field strains may be detected, but the vaccine itself cannot be serologically monitored.

The MSD Veterinary Manual provides detailed comparisons of vaccine strains, administration routes, and age restrictions that vary by jurisdiction. The choice of vaccine affects also herd immunity but also the interpretive framework for all subsequent serological testing.

Regulatory Frameworks and Eradication Programs

Brucellosis control operates within a regulatory context that varies by country but shares common structural elements. The WOAH Terrestrial Animal Health Code defines international standards for surveillance, testing, and trade certification. National programs typically classify herds as free, infected, or suspect based on defined testing protocols and impose movement restrictions accordingly.

Eradication strategies combine test-and-slaughter with vaccination. The historical experience with bovine brucellosis diagnosis and eradication demonstrates that sustained programs can eliminate the disease from national herds, but success depends on high testing compliance, accurate laboratory diagnosis, and effective traceability. The AVMA practice resources offer guidance on the veterinarian's role in reporting, biosecurity, and client communication within these programs.

The practitioner must know the specific requirements of their jurisdiction, including which tests are accepted for official classification, whether vaccination is permitted, and what actions are mandated upon identification of a reactor animal. These requirements are not uniform, and applying the framework of one region to another can lead to regulatory non-compliance.

Diagnostic Testing Algorithm

The diagnostic approach to bovine brucellosis follows a two-tier structure in most regulated programs: screening with a high-sensitivity assay, then confirmation with a high-specificity assay. This sequence exists because no single serological test combines sufficient sensitivity and specificity for individual animal classification in eradication settings. The WOAH terrestrial animal health standards define the internationally accepted test combinations and the conditions under which each assay may be used for trade and movement certification.

The algorithm begins with herd-level risk assessment. Test all adult cattle in a herd when any of the following triggers are present: abortion storm, one or more abortions in an unvaccinated herd, positive bulk milk ELISA, or purchase of animals from a herd of unknown status. Individual animal testing is indicated for pre-purchase screening, pre-breeding evaluation of bulls, and investigation of suspected exposure.

Stepwise Testing Sequence

1. Screening: Rose Bengal test (RBT) or indirect ELISA on serum. Both assays detect antibodies against smooth lipopolysaccharide (LPS). The RBT is inexpensive, rapid, and suitable for on-farm or laboratory use. ELISA platforms offer automation and objective reading, making them preferable for high-throughput laboratories.
2. Confirmation: Complement fixation test (CFT) on all screening-positive samples. The CFT is the traditional confirmatory assay in most eradication programs because of its high specificity. It detects complement-fixing antibodies, predominantly IgG1, which appear later in infection and persist for a variable duration.
3. Interpretation: A positive screening test followed by a positive CFT classifies the animal as a reactor. A positive screening test with a negative CFT requires repeat testing after 30 to 60 days. Persistent screening-positive, CFT-negative results raise the possibility of false-positive reactions, which are discussed below.

The serological cross-reactivity between Brucella abortus and Yersinia enterocolitica O:9 complicates this algorithm. Experimentally infected heifers developed CFT and serum agglutination test titres comparable to natural false-positive reactors after intravenous Yersinia exposure. This finding underscores that a single positive screening result is never sufficient for a regulatory diagnosis.

Confirmatory Testing and Ancillary Assays

The CFT remains the workhorse confirmatory test, but it has limitations. It requires careful titration of complement and hemolysin, fresh reagents, and experienced personnel. Results can be affected by anticomplementary activity in hemolysed or contaminated sera. Laboratories participating in eradication programs must maintain rigorous quality assurance, including participation in proficiency testing schemes.

The gamma interferon (IFN-gamma) assay offers an alternative approach that measures cell-mediated immunity instead of antibody. An in vitro antigen-specific gamma interferon test using cytoplasmic proteins from Brucella melitensis B115 detected infection in more animals than any combination of serological tests during experimental infection and field outbreaks, and it detected infection earlier. Importantly, none of the samples from cows with false-positive serological reactions was classified as positive by the IFN-gamma assay.

However, the specificity of the IFN-gamma assay is antigen-dependent. A later study using Brucellergen as the stimulating antigen found that the IFN-gamma assay could not be used as a specific and discriminatory test for B. abortus infection. After oral exposure to Y. enterocolitica O:9, 80% of heifers showed stimulation indices above the cut-off of 2.5. The choice of antigen preparation is therefore critical, and laboratories must validate their specific assay configuration against local cross-reacting organizms.

Bacteriological culture remains the definitive diagnostic method. Collect samples from placental tissue, fetal abomasal contents, uterine discharge, milk, or supramammary lymph nodes. Culture requires biosafety level 3 facilities and takes 7 to 14 days. Polymerase chain reaction assays on the same samples provide faster results but are not universally standardized for regulatory use.

Rapid and Emerging Test Formats

The enzymatic rapid immunofiltration assay (ERIFA) represents a point-of-care format that detects anti-Brucella antibodies within 5 minutes. When configured with LPS, cell lysate, or O-polysaccharide antigens, ERIFA showed excellent agreement with indirect ELISAs on 420 bovine serum samples. The LPS-deprived chromatographic fraction performed less well, indicating that the LPS component is essential for diagnostic sensitivity. This format may be useful for on-farm screening in settings where laboratory access is limited, but it does not replace regulated confirmatory testing.

Spectroscopic approaches combined with machine learning have been explored for photodiagnosis of Brucella abortus serological status. UV-vis spectroscopy of serum with principal component analysis showed promise in preliminary clustering, but the technique remains experimental and requires validation against established assays before clinical use.

Control Plan Checklist

A comprehensive control plan integrates vaccination, testing, and biosecurity. The Society for Theriogenology resources provide practical guidance on reproductive health management that supports brucellosis control, including abortion investigation protocols and biosecurity for breeding operations.

The MSD Veterinary Manual professional edition provides additional detail on clinical management and herd-level disease control principles that apply to brucellosis programs.

Documentation and Regulatory Reporting

Accurate documentation is a legal obligation in regulated programs. Record the following for every animal tested: permanent identification, age, sex, breed, vaccination status, test date, assay used, antigen lot number, result, and the identity of the testing laboratory. Maintain herd-level records of abortion events, purchased animals, and movement history.

Reporting requirements vary by jurisdiction. The American Veterinary Medical Association practice resources outline the veterinarian's role in notifying state or federal animal health authorities of suspected or confirmed cases. In most programs, brucellosis is a reportable disease, and laboratory-confirmed reactors trigger herd quarantine and epidemiological investigation. Veterinarians must know the specific requirements in their jurisdiction before initiating testing, because the choice of confirmatory assay and the handling of reactors may be prescribed by regulation.

Test Selection by Production System

Dairy herds with bulk tank milk testing programs can use milk ELISA as a herd-level screening tool. Positive bulk milk results require individual animal serum testing to identify reactors. Beef herds typically rely on individual animal testing at the time of pregnancy examination or pre-sale. Cow-calf operations with extensive management may find the RBT more practical than ELISA because it requires no specialised equipment.

The complement fixation test for humoral immunity assessment has a specific role in evaluating response to RB51 vaccination. Because RB51 lacks the O-chain, standard serological tests do not detect vaccinated animals. A CF test using RB51 as antigen can specifically detect antibodies following vaccination in cattle and sheep, which may be useful for confirming vaccine take or investigating suspected RB51 infection in humans. This assay is not part of standard eradication programs but may be requested in occupational health contexts.

Recognized Complications and Failure Modes

The principal failure mode in bovine brucellosis diagnosis is the false-positive reactor. Cross-reacting antibodies from Yersinia enterocolitica O:9 infection produce serological responses that mimic natural Brucella abortus infection, particularly in the complement fixation test and serum agglutination test. Experimental work in heifers has shown that intravenous exposure to Y. enterocolitica O:9 generates CFT and SAT titres and card test reactions comparable to genuine false-positive brucellosis reactors, while oral exposure produces only minimal conventional test responses Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0:9. The discriminating feature is that the gamma interferon response to Brucellergen peaks after oral yersinial exposure but falls after intravenous exposure, the opposite of what occurs in true B. abortus infection.

A second failure mode is the vaccinated animal. Strain RB51 does not induce antibodies detectable by conventional LPS-based serological tests, which complicates both vaccination monitoring and the interpretation of reactors in vaccinated herds. A complement fixation test using RB51 as antigen can detect anti-RB51 antibodies in vaccinated cattle and sheep, providing a means to distinguish vaccinal from field infection Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.

A third failure mode is the infected animal that tests negative. Early infection, low-level shedding, and immunologically suppressed animals can all produce false-negative results on single sampling. The gamma interferon assay detects infection earlier than any combination of serological tests in experimentally infected heifers and in field outbreak cows, and it correctly classifies animals with false-positive serological reactions as negative Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Common Diagnostic Errors

The most frequent error is over-reliance on a single screening test. Screening assays such as the Rose Bengal test have high sensitivity but imperfect specificity, and a positive result demands confirmatory testing before any regulatory action. A second error is ignoring vaccination history when interpreting serology. Smooth strain S19 vaccination can produce persistent titres that confound interpretation for months, while RB51 vaccination produces no LPS antibodies at all, so a positive LPS-based test in an RB51-vaccinated herd is genuinely suspicious.

A third error is sampling at the wrong time. Testing acutely ill animals during the febrile phase may yield negative results because antibody titres have not yet risen. Testing very young calves can detect maternal antibody. Testing bulls adds little to herd-level diagnosis because the disease spreads primarily through reproductive tissues and milk.

The corrective action is to follow a structured algorithm: screen, confirm, and culture when the epidemiological context demands it. The gamma interferon assay is particularly useful in herds with a history of false-positive serological reactions, because it does not classify these animals as positive Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production. Rapid test formats based on enzymatic immunofiltration show excellent agreement with indirect ELISA and can identify reactor animals within minutes, but they should not replace confirmatory testing in regulatory contexts Development of an individual rapid test based on enzymatic immunofiltration assay for detection of anti-Brucella abortus antibody in bovine sera.

Limitations of Current Evidence

The evidence base for bovine brucellosis diagnostics has several gaps. The gamma interferon assay illustrates the problem: one experimental study found it highly specific and sensitive, while a later study using a different antigen preparation found it could not discriminate B. abortus infection from Y. enterocolitica O:9 exposure Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0:9. The discrepancy likely reflects differences in antigen preparation and test protocol, but it means the assay is not standardized across laboratories.

Expert opinion differs on the role of vaccination in eradication programs. Some programs rely on vaccination as the primary control measure, while others prohibit vaccination entirely and rely on test-and-slaughter. The choice depends on disease prevalence, herd size, and regulatory policy, and there is no universally correct answer. The World Organization for Animal Health provides international standards for surveillance and trade, but national programs vary substantially in their testing requirements and response protocols WOAH terrestrial animal health standards.

Referral and Reporting Triggers

Any positive confirmatory test for B. abortus is a reportable event in most jurisdictions. The veterinarian should contact the relevant animal health authority immediately, before taking further samples or moving animals. Referral to a diagnostic laboratory is warranted for culture, which is the definitive confirmation of infection and provides the strain information needed for epidemiological tracing.

Specialist consultation is appropriate when a herd has persistent false-positive reactors that cannot be resolved with standard testing, when the gamma interferon assay is being considered as an adjunct to serology, or when designing a vaccination strategy for a herd with a known infection risk. The Society for Theriogenology provides resources on reproductive health management that may assist in these cases Society for Theriogenology resources. The MSD Veterinary Manual offers additional reference material on clinical presentation and diagnostic interpretation MSD Veterinary Manual professional edition.

Frequently Asked Questions

How Do I Interpret a Positive Screening Test When Confirmatory Testing Is Not Immediately Available?

A positive Rose Bengal test or ELISA result is not a diagnosis. The predictive value of a positive screening result depends heavily on the herd's true prevalence and vaccination history. In a low-prevalence area, most positive screening results will be false positives. You should immediately isolate the animal, flag it in your records, and collect a second sample for confirmatory testing. Do not advise the client to cull or treat based on screening alone. If confirmatory testing is delayed, maintain the animal's isolation and restrict movement. The WOAH terrestrial animal health standards provide guidance on interpreting test results in the context of official surveillance programs.

What Do I Do When the Laboratory Rejects My Samples as Unsuitable?

Sample rejection most often results from hemolysis, bacterial contamination, or improper temperature during transport. If you cannot obtain a clean venipuncture, wait 24 to 48 hours and re-collect. Use plain serum separator tubes, allow full clot retraction, and centrifuge before shipping. Ship samples chilled, not frozen, unless the laboratory specifies otherwise. If the laboratory is closed for several days, freeze separated serum and ship on cold packs. Document the rejection and resubmission in the case record. When a second sample is also rejected, contact the laboratory to discuss alternative sample types, such as plasma, and confirm their acceptance criteria before resubmitting.

How Should I Advise a Client Who Refuses to Cull a Confirmed Reactor?

Explain that regulatory programs do not permit treatment or retention of confirmed reactors in most jurisdictions. The AVMA practice resources emphasize that veterinarians must balance client interests with public health obligations. Focus the conversation on herd-level risk. A single retained reactor can serve as a persistent source of exposure for the rest of the herd, and the economic cost of a prolonged quarantine or loss of market access will exceed the value of one animal. Offer alternatives where they exist, such as voluntary depopulation with indemnity, but be explicit that retention is not a legal option in regulated programs. Document the conversation and the client's decision in writing.

How Do I Manage Brucellosis Testing in a Herd with a Recent Vaccination History?

Vaccination with B. abortus strain 19 can produce persistent serological titres that interfere with standard assays for months or years. The RB51 vaccine does not induce antibodies detectable by conventional LPS-based tests, which is its principal diagnostic advantage. However, RB51 vaccination can complicate interpretation of tests designed to detect rough strains. The complement fixation test using RB51 as antigen can specifically detect antibodies following RB51 vaccination, which may be useful in occupational exposure investigations. For routine herd testing, record the vaccine type and date for every animal, and interpret results against the known vaccination window. Consult your regulatory authority for the accepted interval between vaccination and official testing.

What Is the Minimum Equipment I Need to Perform On-Farm Screening?

On-farm screening requires a refrigerated centrifuge, serum separator tubes, a cold transport container, and a reliable courier arrangement. The Rose Bengal test can be performed on-farm with a card, antigen, and pipette, but interpretation is subjective and the test is not suitable as a sole diagnostic. The enzymatic rapid immunofiltration assay has been evaluated as an individual rapid test that can identify reactors within five minutes, but it is not widely available commercially. For most practices, the most practical approach is to collect and process serum on-farm, then ship to an accredited laboratory. Do not attempt to interpret agglutination tests without proper training and positive and negative controls.

How Do I Explain the Difference Between Vaccination Titres and True Infection to a Producer?

Use a direct analogy. Vaccination is like a training exercise for the immune system, it produces antibodies that look similar to infection on some tests. Infection is the real event. The laboratory uses a sequence of tests to distinguish between the two. The gamma interferon assay detects cell-mediated immune responses that correlate with active infection, while serological tests detect antibody. However, even the gamma interferon assay has limitations, as shown by cross-reactivity with Yersinia enterocolitica O:9 in experimentally infected cattle. Explain that the testing algorithm is designed to minimize both false positives and false negatives, and that a confirmed reactor represents a regulatory finding, not a laboratory error.

Related Clinical & Scientific Guides

• Diagnostic Approach to Canine Infertility in the Bitch
• Canine Neonatal Resuscitation: Protocol and Monitoring
• Equine Breeding Soundness Examination of the Stallion

References and Further Reading

• Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0:9. III. Specificity of the in vitro antigen-specific gamma interferon test for bovine brucellosis diagnosis in experimentally Yersinia enterocolitica 0:9-infected cattle.. 1997.
• Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.. 1999.
• Turning chaotic sample group clusterization into organized ones by feature selection: Application on photodiagnosis of Brucella abortus serological test.. 2023.
• Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.. 1995.
• Development of an individual rapid test based on enzymatic immunofiltration assay for detection of anti-Brucella abortus antibody in bovine sera.. 2011.
• Bovine brucellosis - diagnosis and eradication.. 1985.
• Society for Theriogenology Resources. Society for Theriogenology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Dystocia in Cattle: Causes, Diagnosis, and Management
• Caprine Brucellosis: Diagnosis and Management
• Equine Brucellosis: Diagnosis and Management
• Ovine Brucellosis: Diagnosis and Management
• Pregnancy Diagnosis in Cattle: Methods and Accuracy

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.